» Articles » PMID: 32931886

Romance of the Three Kingdoms in Hypoxia: HIFs, Epigenetic Regulators, and Chromatin Reprogramming

Overview
Journal Cancer Lett
Specialty Oncology
Date 2020 Sep 15
PMID 32931886
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia is a hallmark of cancer. To cope with hypoxic conditions, tumor cells alter their transcriptional profiles mainly through hypoxia-inducible factors (HIFs) and epigenetic reprogramming. Hypoxia, in part through HIF-dependent mechanisms, influences the expression or activity of epigenetic regulators to control epigenetic reprogramming, including DNA methylation and histone modifications, which regulate hypoxia-responsive gene expression in cells. Conversely, epigenetic regulators and chromatin architecture can modulate the expression, stability, or transcriptional activity of HIF. Understanding the complex networks between HIFs, epigenetic regulators, and chromatin reprogramming in response to hypoxia will provide insight into the fundamental mechanism of transcriptional adaptation to hypoxia, and may help identify novel targets for future therapies. In this review, we will discuss the comprehensive relationship between HIFs, epigenetic regulators, and chromatin reprogramming under hypoxic conditions.

Citing Articles

Role of Hypoxia-Associated Long Noncoding RNAs in Cancer Chemo-Therapy Resistance.

Elahi M, Tariq A, Malik A, Zhra M Int J Mol Sci. 2025; 26(3).

PMID: 39940704 PMC: 11817469. DOI: 10.3390/ijms26030936.


Characteristics of transcriptome and chromatin accessibility in the peripheral blood after acute hypoxia exposure.

Zeng K, Yuan P, Xuan J, Zhao L, Li X, Yao J BMC Biol. 2025; 23(1):19.

PMID: 39838410 PMC: 11752951. DOI: 10.1186/s12915-025-02123-z.


Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets.

Nisar A, Khan S, Li W, Hu L, Samarawickrama P, Gold N MedComm (2020). 2024; 5(11):e786.

PMID: 39415849 PMC: 11480526. DOI: 10.1002/mco2.786.


VHL suppresses UBE3B-mediated breast tumor growth and metastasis.

Wang S, Li H, Liu X, Yin T, Li T, Zheng M Cell Death Dis. 2024; 15(6):446.

PMID: 38914543 PMC: 11196597. DOI: 10.1038/s41419-024-06844-x.


Metabolic memory: mechanisms and diseases.

Dong H, Sun Y, Nie L, Cui A, Zhao P, Leung W Signal Transduct Target Ther. 2024; 9(1):38.

PMID: 38413567 PMC: 10899265. DOI: 10.1038/s41392-024-01755-x.